68 virtualization-"https:"-"https:"-"https:" positions at Center for Drug Evaluation and Research (CDER)

FDA Studying the Critical Quality Attributes of Multispecific Antibodies/Fusion Proteins (SARITA 4400)

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 4 days ago

antibodies and fusion proteins. Design and develop optimized bioassays that detect signal transduction downstream of receptor binding and identify signal transduction pathways most relevant to the mechanism

FDA Application of Quantitative Approaches to Streamline Drug Development and Enhance Patient Care

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 4 days ago

. Mentor: If you have questions about the nature of the research, please contact the mentors at dpm-contact@fda.hhs.gov . Anticipated Appointment Start Date: 2026. Start date is flexible and will depend on a

FDA Research Opportunity - Analysis of Patient Diversity and Ineligibility Rates in Cancer Pivotal Clinical Trials

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 4 days ago

Cao (Ling.Cao@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentors. Anticipated Appointment Start Date: 2026. Start date is flexible and will depend on a

FDA Development of Cell-based Reporter Assays for FSH, LH and hCG

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 4 days ago

the chance to: Gain knowledge about reproductive hormone therapies. Gain knowledge about development of cell-based bioassays. Perform hands-on experiment to learn laboratory techniques including cell

FDA Characterization of Topical Spray Drug Products

Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | 4 days ago

research and activities. Learning Objectives: Under the guidance of the mentor(s), you will learn about: Developing project-specific protocols and methodology using state-of-the-art instrumentation, such as

FDA Drug Product Quality Assessment

Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | 4 days ago

explored, to find the most effective means to quantify trace benzene in a variety of sample types. Mentor: The mentor for this opportunity is Matthew Stark (Matthew.Stark@fda.hhs.gov ). If you have questions

FDA Artificial Intelligence and Open-Source Data for Advanced Quality Surveillance

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 4 days ago

analysis, web-scraping, and traditional statistical methods. This will transform OQS surveillance operations while providing educational opportunities for staff to learn about the regulatory landscape and

FDA Regulatory Analysis of Dose-Finding and Optimization Approaches in Targeted Oncology Therapeutics

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 4 days ago

the project you will learn about: Understanding oncology-specific dosage considerations including the transition from MTD to optimized dosing paradigms, the role of totality evidence in dosage selection, and

FDA Bioequivalence of Complex Generic Products Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 4 days ago

vivo, and/or in silico study designs for establishing bioequivalence with these products. Mentor: The mentor for this opportunity is Yan Wang (Yan.Wang3@fda.hhs.gov ). If you have questions about the

FDA Development of Analytical Methods to Assess Nitrosamine Impurities in Over-the-Counter (OTC) Monograph Drug Products

Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | 4 days ago

@fda.hhs.gov ) and Tim Marzan (TimAndres.Marzan@fda.hhs.gov ). If you have questions about the nature of the research, please contact the mentors. Anticipated Appointment Start Date: 2026. Start date is flexible